Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03651531 · ClinicalTrials.gov registry record · Phase 3
Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus
A Phase 3 study, sponsored by Women and Infants Hospital of Rhode Island.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT03651531 is a Phase 3 study that was terminated before completion, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 1 participants.
The verdict
NCT03651531, a Phase 3 study, was terminated before completion, sponsored by Women and Infants Hospital of Rhode Island.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is a prospective, unmasked randomized clinical trial comparing the use of insulin vs combination insulin and metformin for treatment in women diagnosed with gestational diabetes mellitus (GDM). The investigator's hypothesis is that the combination of metformin and insulin will be superior to insulin alone to achieve tight glucose control during pregnancy.
Interventions
- DRUG Metformin
- DRUG Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-01-03 |
| Est. Completion | 2019-07-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03651531
The ClinicalTrials.gov registry entry for NCT03651531 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT03651531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03651531 about?
NCT03651531 is a clinical study titled "Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus". This study is a prospective, unmasked randomized clinical trial comparing the use of insulin vs combination insulin and metformin for treatment in women diagnosed with gestational diabetes mellitus (GDM). The investigator's hypothesis is that the combination of metformin and insulin will be superior...
What is the current status of trial NCT03651531?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2018-01-03. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT03651531?
The interventions under investigation include: Metformin (DRUG), Insulin (DRUG).
Who is sponsoring clinical trial NCT03651531?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.